New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Facility-level disparities linked to racial health inequality among prostate cancer patients

Facility-level disparities linked to racial health inequality among prostate cancer patients

Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-lev
World medicine November 25,2023
Facility-level disparities linked to racial health inequality among prostate cancer patients

Facility-level disparities linked to racial health inequality among prostate cancer patients

Racial minorities in the United States are less likely to receive treatment for prostate cancer and, overall, have worse survival outcomes compared to individuals who are white. Typically, patient-lev
World medicine November 25,2023
Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an ave
World medicine November 25,2023
Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Advanced pancreatic cancer model more accurately depicts PDAC tumor progression

Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an ave
World medicine November 25,2023
BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM1.0 in Slovakia, in collaboration with its local partner, Zentya. Zentya is a Slovak-based healthcare solution provider that is passio
World medicine November 25,2023
BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics and Zentya collaborate to launch first-ever fecal DNA tests for colorectal cancer in Slovakia

BGI Genomics is pleased to announce the launch of COLOTECTTM1.0 in Slovakia, in collaboration with its local partner, Zentya. Zentya is a Slovak-based healthcare solution provider that is passio
World medicine November 25,2023
Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney,
World medicine November 25,2023
Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney,
World medicine November 25,2023
IU Cancer Center secures new, renewed ACS funding to support research and education programs

IU Cancer Center secures new, renewed ACS funding to support research and education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support researc
World medicine November 25,2023
IU Cancer Center secures new, renewed ACS funding to support research and education programs

IU Cancer Center secures new, renewed ACS funding to support research and education programs

As part of a longstanding partnership, the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has received new and renewed funding from the American Cancer Society to support researc
World medicine November 25,2023
Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients sur
World medicine November 25,2023
Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients sur
World medicine November 25,2023
Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness, neuropsychiatric disability, or substance abuse are less likely to go for gynecological smear tests for cervical cancer and run more than twice the risk of developing the di
World medicine November 25,2023
Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness have twice the risk of developing cervical cancer

Women with mental illness, neuropsychiatric disability, or substance abuse are less likely to go for gynecological smear tests for cervical cancer and run more than twice the risk of developing the di
World medicine November 25,2023
Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stres
World medicine November 25,2023
Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Hospitalist comanagement associated with shorter length of hospital stay for cancer patients

Involving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increased inpatient hospital capacity, and reduced stres
World medicine November 25,2023
New combination therapy shows promising results in some patients with advanced head and neck cancer

New combination therapy shows promising results in some patients with advanced head and neck cancer

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in theJournal of Clinic
World medicine November 25,2023
New combination therapy shows promising results in some patients with advanced head and neck cancer

New combination therapy shows promising results in some patients with advanced head and neck cancer

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in theJournal of Clinic
World medicine November 25,2023
TiY: Cancer diagnosis and treatment in a single step

TiY: Cancer diagnosis and treatment in a single step

Cancer is not incurable anymore. Nevertheless, according to statistics released by Statistics Korea last year, cancer remained the primary cause of mortality in Korea in 2021. This highlights the ongo
World medicine November 25,2023
TiY: Cancer diagnosis and treatment in a single step

TiY: Cancer diagnosis and treatment in a single step

Cancer is not incurable anymore. Nevertheless, according to statistics released by Statistics Korea last year, cancer remained the primary cause of mortality in Korea in 2021. This highlights the ongo
World medicine November 25,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com